Integrin β4, relying on the regulation of TNFAIP2 and IQGAP1, effectively activated RAC1, promoting the migration of TNBC cells while enhancing the resistance of cancer cells to DNA damage-related therapies [30]. The gene discussed is TNFAIP2; the disease is cancer.